Conclusion: Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
PubMed 30097390 ↗Bupropion
Also known as Wellbutrin, Zyban
The short answer. People are split on Bupropion — 41% of 271 say it helped. It is most often used for mood: 70% of 172 reports say that improved. It is well studied — 411 meta-analyses on PubMed. The most common complaint is anxiety.
From 444 mentions in total — the rest didn't say how it went and aren't counted.
What Bupropion does, according to users
Of the people who reported each effect, the share who said it got better.
1 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 411 meta-analyses on PubMed ↗ · 617 randomized trials ↗
Conclusion: In adults with overweight and obesity, phentermine-topiramate and GLP-1 receptor agonists proved the best drugs in reducing weight; of the GLP-1 agonists, semaglutide might be the most effective.
PubMed 38582569 ↗Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.
PubMed 36253442 ↗Conclusion: Cytisine shows greater efficacy than placebo and NRT, but more adverse events. It is comparable to varenicline, with fewer adverse events. This can inform clinicians and guidelines on cytisine for smoking cessation.
PubMed 37678096 ↗508 human trials on ClinicalTrials.gov test Bupropion — 368 completed, 26 recruiting now. See all on ClinicalTrials.gov ↗
- Pharmacological and Behavioral Treatment After Bariatric Surgery · Obesity · 2026
- Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants · Drug Drug Interaction · 2025
- Treating Negative Affect in Low Back Pain Patients · Chronic Low Back Pain, Negative Affectivity · 2024
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with…”
The FDA found Bupropion as an undeclared ingredient in 1 product sold as supplements, most recently on 2024-10-30. FDA tainted-products database ↗
39 recalls of products named for Bupropion. Most recent:
- 2025-10-29 · Class II: Failed Tablet/Capsule Specifications record ↗
- 2024-07-17 · Class II: Failed Dissolution Specifications; the product is dissolving faster than the specified limits. record ↗
- 2024-01-17 · Class II: Presence of Foreign Tablets/Capsules record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
140,700 adverse-event reports mention Bupropion. Most often reported:
- Drug ineffective · 12,623
- Nausea · 9,835
- Fatigue · 9,438
- Headache · 8,846
- Depression · 8,333
- Anxiety · 7,199
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Bupropion C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 60 research projects with Bupropion in the title, $69,337,797 in total (1992–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Bupropion ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“It really helped. I went from being suicidal to having hope and motivation within 3 days of starting the medication.”
“it might boost neurogenesis and makes me energetic. The drawbacks are higher heart rate and somewhat worse memory.”
“I've been on welbutrin for off-label ADHD-i treatment for almost 6 years. It's changed everything - keeps me pretty level, keeps me focused.”
“Yes tried wellbutrin made me kind of ok then made my ocd worse.”
Top discussions (5)
- Not everything can be fixed with "diet, sleep, exercise" ↗
- What have you found gets you wakeful and energetic without caffeine ↗
- How taking an SSRI antidepressant (Celexa) at the lowest dose just for 3 weeks for generalized anxiety disorder in 2019 ruined my whole life. ↗
- Reta is killing every single one of my bad habits... ↗
- Retatrutide causing emotional numbness and loss of motivation? ↗
Bupropion compared
Other options for mood
Sources
- User reports: 444 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- FDA tainted-products database ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate